Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 144 articles: HTML format

Single Articles

September 2021
1. XIA H, Li Y, Lv X
   [Retracted] MicroRNA107 inhibits tumor growth and metastasis by targeting the BDNFmediated PI3K/AKT pathway in human nonsmall lung cancer.
   Int J Oncol. 2021;59.
   PubMed     Abstract available
   
   
   June 2021
2. WANG D, Wu J, Wang D, Huang X, et al
   Cisplatin enhances protein OGlcNAcylation by altering the activity of OGT, OGA and AMPK in human nonsmall cell lung cancer cells.
   Int J Oncol. 2021;58.
   PubMed     Abstract available
   
   
   
3. MORELLI AP, Tortelli TC Jr, Pavan ICB, Silva FR, et al
   Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways.
   Int J Oncol. 2021;58.
   PubMed     Abstract available
   
   
   December 2020
4. ZAKARIA MA, Rajab NF, Chua EW, Selvarajah GT, et al
   Roles of Rhoassociated kinase in lung cancer (Review).
   Int J Oncol. 2020 Dec 24. doi: 10.3892/ijo.2020.5164.
   PubMed     Abstract available
   
   
   
5. SONG H, Li H, Ding X, Li M, et al
   Long noncoding RNA FEZF1AS1 facilitates nonsmall cell lung cancer progression via the ITGA11/miR516b5p axis.
   Int J Oncol. 2020;57:1333-1347.
   PubMed     Abstract available
   
   
   
6. LI M, Rui Y, Peng W, Hu J, et al
   FIGNL1 promotes nonsmall cell lung cancer cell proliferation.
   Int J Oncol. 2020 Dec 1. doi: 10.3892/ijo.2020.5154.
   PubMed     Abstract available
   
   
   November 2020
7. KONG HJ, Kwon EJ, Kwon OS, Lee H, et al
   Crosstalk between YAP and TGFbeta regulates SERPINE1 expression in mesenchymal lung cancer cells.
   Int J Oncol. 2020 Nov 27. doi: 10.3892/ijo.2020.5153.
   PubMed     Abstract available
   
   
   September 2020
8. LI J, Zhao L, Pan Y, Ma X, et al
   SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in nonsmall cell lung cancer.
   Int J Oncol. 2020;57:756-766.
   PubMed     Abstract available
   
   
   August 2020
9. SHEN M, Chen Y, Xu L, Zhu R, et al
   [Corrigendum] Increased infiltration of macrophages to radioresistant lung cancer cells contributes to the development of the additional resistance of tumor cells to the cytotoxic effects of NK cells.
   Int J Oncol. 2020 Aug 19. doi: 10.3892/ijo.2020.5113.
   PubMed     Abstract available
   
   
   
10. SHEN Q, Xu Z, Xu S
    Long noncoding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR514a3p/ULK1 axis in human nonsmall cell lung cancer.
    Int J Oncol. 2020 Aug 7. doi: 10.3892/ijo.2020.5106.
    PubMed     Abstract available
    
    
    
11. XU WT, Shen GN, Li TZ, Zhang Y, et al
    Isoorientin induces the apoptosis and cell cycle arrest of A549 human lung cancer cells via the ROSregulated MAPK, STAT3 and NFkappaB signaling pathways.
    Int J Oncol. 2020;57:550-561.
    PubMed     Abstract available
    
    
    
12. CHEN L, Li X, Lu C, Zhao Y, et al
    The long noncoding RNA CASC7 inhibits growth and invasion of nonsmall cell lung cancer cells through phosphatase and tensin homolog upregulation via sequestration of miR92a.
    Int J Oncol. 2020;57:466-477.
    PubMed     Abstract available
    
    
    June 2020
13. CHENG L, Gou L, Wei T, Zhang J, et al
    GBP1 promotes erlotinib resistance via PGK1activated EMT signaling in nonsmall cell lung cancer.
    Int J Oncol. 2020 Jun 22. doi: 10.3892/ijo.2020.5086.
    PubMed     Abstract available
    
    
    May 2020
14. LIU Y, Xu P, Liu H, Fang C, et al
    Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model.
    Int J Oncol. 2020 May 26. doi: 10.3892/ijo.2020.5073.
    PubMed     Abstract available
    
    
    
15. WANG M, Sun XY, Zhou YC, Zhang KJ, et al
    Suppression of Musashi2 by the small compound largazole exerts inhibitory effects on malignant cells.
    Int J Oncol. 2020;56:1274-1283.
    PubMed     Abstract available
    
    
    April 2020
16. MIRZAPOIAZOVA T, Pozhitkov A, Nam A, Mambetsariev I, et al
    Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines.
    Int J Oncol. 2020 Apr 1. doi: 10.3892/ijo.2020.5034.
    PubMed     Abstract available
    
    
    March 2020
17. KIM JH, Ko ES, Kim D, Park SH, et al
    Cancer cellspecific anticancer effects of Coptis chinensis on gefitinibresistant lung cancer cells are mediated through the suppression of Mcl1 and Bcl2.
    Int J Oncol. 2020 Mar 24. doi: 10.3892/ijo.2020.5025.
    PubMed     Abstract available
    
    
    
18. ZAMAGNI A, Pasini A, Pirini F, Ravaioli S, et al
    CDKN1A upregulation and cisplatinpemetrexed resistance in nonsmall cell lung cancer cells.
    Int J Oncol. 2020 Mar 24. doi: 10.3892/ijo.2020.5024.
    PubMed     Abstract available
    
    
    
19. DRZEWIECKA H, Jarmolowska-Jurczyszyn D, Kluk A, Galecki B, et al
    Altered expression of 17betahydroxysteroid dehydrogenase type 2 and its prognostic significance in nonsmall cell lung cancer.
    Int J Oncol. 2020 Mar 19. doi: 10.3892/ijo.2020.5014.
    PubMed     Abstract available
    
    
    
20. ZHAO J, Xue X, Fu W, Dai L, et al
    Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatinresistant nonsmall cell lung cancer.
    Int J Oncol. 2020 Mar 4. doi: 10.3892/ijo.2020.5003.
    PubMed     Abstract available
    
    
    
21. CHIHARA Y, Iizumi Y, Horinaka M, Watanabe M, et al
    Histone deacetylase inhibitor OBP801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1dependent apoptosis.
    Int J Oncol. 2020;56:848-856.
    PubMed     Abstract available
    
    
    
22. LIU T, Zhao X, Zheng X, Zheng Y, et al
    The EMT transcription factor, Twist1, as a novel therapeutic target for pulmonary sarcomatoid carcinomas.
    Int J Oncol. 2020;56:750-760.
    PubMed     Abstract available
    
    
    
23. HORIUCHI S, Saito Y, Matsui A, Takahashi N, et al
    A novel loopmediated isothermal amplification method for efficient and robust detection of EGFR mutations.
    Int J Oncol. 2020;56:743-749.
    PubMed     Abstract available
    
    
    February 2020
24. LIU XF, Han Q, Rong XZ, Yang M, et al
    ANKHD1 promotes proliferation and invasion of nonsmallcell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
    Int J Oncol. 2020 Feb 19. doi: 10.3892/ijo.2020.4994.
    PubMed     Abstract available
    
    
    January 2020
25. KO PH, Lenka G, Chen YA, Chuang EY, et al
    Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
    Int J Oncol. 2020;56:165-177.
    PubMed     Abstract available
    
    
    
26. NAKANO Y, Isobe K, Kobayashi H, Kaburaki K, et al
    Clinical importance of long noncoding RNA LINC00460 expression in EGFRmutant lung adenocarcinoma.
    Int J Oncol. 2020;56:243-257.
    PubMed     Abstract available
    
    
    December 2019
27. PARK S, Lim JM, Chun JN, Lee S, et al
    Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in nonsmall cell lung cancer.
    Int J Oncol. 2019 Dec 24. doi: 10.3892/ijo.2019.4953.
    PubMed     Abstract available
    
    
    
28. ZENG SG, Lin X, Liu JC, Zhou J, et al
    [Corrigendum] Hypoxiainduced internalization of connexin 26 and connexin 43 in pulmonary epithelial cells is involved in the occurrence of nonsmall cell lung cancer via the P53/MDM2 signaling pathway.
    Int J Oncol. 2019 Dec 17. doi: 10.3892/ijo.2019.4906.
    PubMed     Abstract available
    
    
    
29. REN T, Fan XX, Wang MF, Duan FG, et al
    miR20b promotes growth of nonsmall cell lung cancer through a positive feedback loop of the Wnt/betacatenin signaling pathway.
    Int J Oncol. 2019 Dec 13. doi: 10.3892/ijo.2019.4940.
    PubMed     Abstract available
    
    
    
30. DING Z, Du W, Lei Z, Zhang Y, et al
    Neuropilin 1 modulates TGFbeta1induced epithelialmesenchymal transition in nonsmall cell lung cancer.
    Int J Oncol. 2019 Dec 11. doi: 10.3892/ijo.2019.4938.
    PubMed     Abstract available
    
    
    
31. YUAN M, Xie F, Xia X, Zhong K, et al
    UNC5Cknockdown enhances the growth and metastasis of breast cancer cells by potentiating the integrin alpha6/beta4 signaling pathway.
    Int J Oncol. 2019 Dec 2. doi: 10.3892/ijo.2019.4931.
    PubMed     Abstract available
    
    
    November 2019
32. LING B, Liao X, Huang Y, Liang L, et al
    Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments.
    Int J Oncol. 2019 Nov 28. doi: 10.3892/ijo.2019.4926.
    PubMed     Abstract available
    
    
    October 2019
33. WANG M, Xie S, Yuan W, Xie T, et al
    Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer.
    Int J Oncol. 2019 Oct 14. doi: 10.3892/ijo.2019.4899.
    PubMed     Abstract available
    
    
    September 2019
34. FERREIRA IG, Carrascal M, Mineiro AG, Bugalho A, et al
    Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an Eselectin ligand in nonsmall cell lung cancer.
    Int J Oncol. 2019 Sep 26. doi: 10.3892/ijo.2019.4886.
    PubMed     Abstract available
    
    
    
35. ZENG SG, Lin X, Liu JC, Zhou J, et al
    Hypoxiainduced internalization of connexin 26 and connexin 43 in pulmonary epithelial cells is involved in the occurrence of nonsmall cell lung cancer via the P53/MDM2 signaling pathway.
    Int J Oncol. 2019 Sep 3. doi: 10.3892/ijo.2019.4867.
    PubMed     Abstract available
    
    
    
36. BIE F, Wang G, Qu X, Wang Y, et al
    Loss of FGL1 induces epithelialmesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
    Int J Oncol. 2019;55:697-707.
    PubMed     Abstract available
    
    
    August 2019
37. HU C, Zhou H, Liu Y, Huang J, et al
    ROCK1 promotes migration and invasion of nonsmallcell lung cancer cells through the PTEN/PI3K/FAK pathway.
    Int J Oncol. 2019 Aug 30. doi: 10.3892/ijo.2019.4864.
    PubMed     Abstract available
    
    
    
38. BU M, Liu X, Liu X, Xu W, et al
    Upregulation of fascin-1 is involved in HIF-1alpha-dependent invasion and migration of hypopharyngeal squamous cell carcinoma.
    Int J Oncol. 2019;55:488-498.
    PubMed     Abstract available
    
    
    July 2019
39. JIANG L, Li Z, Wang R
    Long noncoding RNAs in lung cancer: Regulation patterns, biologic function and diagnosis implications (Review).
    Int J Oncol. 2019 Jul 29. doi: 10.3892/ijo.2019.4850.
    PubMed     Abstract available
    
    
    
40. SHAN L, Zhao M, Lu Y, Ning H, et al
    CENPE promotes lung adenocarcinoma proliferation and is directly regulated by FOXM1.
    Int J Oncol. 2019;55:257-266.
    PubMed     Abstract available
    
    
    June 2019
41. LIU Y, Xie S, Zeng J, Song X, et al
    Adenylyl cyclaseassociated protein 1targeted nanoparticles as a novel strategy for the treatment of metastatic nonsmall cell lung cancer.
    Int J Oncol. 2019 Jun 6. doi: 10.3892/ijo.2019.4822.
    PubMed     Abstract available
    
    
    
42. WANG L, Shi H, Liu Y, Zhang W, et al
    Cystathioninegammalyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
    Int J Oncol. 2019 Jun 6. doi: 10.3892/ijo.2019.4823.
    PubMed     Abstract available
    
    
    
43. SATO H, Soh J, Aoe K, Fujimoto N, et al
    Droplet digital PCR as a novel system for the detection of microRNA34b/c methylation in circulating DNA in malignant pleural mesothelioma.
    Int J Oncol. 2019;54:2139-2148.
    PubMed     Abstract available
    
    
    May 2019
44. LI Y, Yang Y, Gan T, Zhou J, et al
    Extracellular RNAs from lung cancer cells activate epithelial cells and induce neutrophil extracellular traps.
    Int J Oncol. 2019 May 21. doi: 10.3892/ijo.2019.4808.
    PubMed     Abstract available
    
    
    
45. MIN TR, Park HJ, Ha KT, Chi GY, et al
    Suppression of EGFR/STAT3 activity by lupeol contributes to the induction of the apoptosis of human nonsmall cell lung cancer cells.
    Int J Oncol. 2019 May 7. doi: 10.3892/ijo.2019.4799.
    PubMed     Abstract available
    
    
    
46. GAO L, Guo YN, Zeng JH, Ma FC, et al
    The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
    Int J Oncol. 2019;54:1651-1664.
    PubMed     Abstract available
    
    
    
47. XU LH, Zhao F, Yang WW, Chen CW, et al
    MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma.
    Int J Oncol. 2019;54:1579-1590.
    PubMed     Abstract available
    
    
    
48. FANG H, Liu Y, He Y, Jiang Y, et al
    Extracellular vesicledelivered miR5055p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1.
    Int J Oncol. 2019;54:1821-1832.
    PubMed     Abstract available
    
    
    
49. LI S, Ma J, Si Y, Cheng S, et al
    Differential expression and functions of Ehm2 transcript variants in lung adenocarcinoma.
    Int J Oncol. 2019;54:1747-1758.
    PubMed     Abstract available
    
    
    April 2019
50. LI Z, Guo T, Fang L, Li N, et al
    MACC1 overexpression in carcinomaassociated fibroblasts induces the invasion of lung adenocarcinoma cells via paracrine signaling.
    Int J Oncol. 2019;54:1367-1375.
    PubMed     Abstract available
    
    
    March 2019
51. ZHANG J, Li J, Li S, Zhou C, et al
    miR802 inhibits the aggressive behaviors of nonsmall cell lung cancer cells by directly targeting FGFR1.
    Int J Oncol. 2019 Mar 29. doi: 10.3892/ijo.2019.4765.
    PubMed     Abstract available
    
    
    
52. LIU L, Liu L, Lu S
    lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3.
    Int J Oncol. 2019;54:929-941.
    PubMed     Abstract available
    
    
    February 2019
53. JIN X, Luan H, Chai H, Yan L, et al
    Netrin1 interference potentiates epithelialtomesenchymal transition through the PI3K/AKT pathway under the hypoxic microenvironment conditions of nonsmall cell lung cancer.
    Int J Oncol. 2019 Feb 15. doi: 10.3892/ijo.2019.4716.
    PubMed     Abstract available
    
    
    
54. SUN X, Jia M, Sun W, Feng L, et al
    Functional role of RBM10 in lung adenocarcinoma proliferation.
    Int J Oncol. 2019;54:467-478.
    PubMed     Abstract available
    
    
    January 2019
55. WANG Z, Liu G, Jiang J
    Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment using stable isotope labeling with amino acids in cell culture.
    Int J Oncol. 2019 Jan 18. doi: 10.3892/ijo.2019.4690.
    PubMed     Abstract available
    
    
    
56. XU YH, Tu JR, Zhao TT, Xie SG, et al
    [Corrigendum] Overexpression of lncRNA EGFRAS1 is associated with a poor prognosis and promotes chemotherapy resistance in nonsmall cell lung cancer.
    Int J Oncol. 2019 Jan 14. doi: 10.3892/ijo.2019.4686.
    PubMed     Abstract available
    
    
    
57. SANG Y, Sun L, Wu Y, Yuan W, et al
    Histone deacetylase 7 inhibits plakoglobin expression to promote lung cancer cell growth and metastasis.
    Int J Oncol. 2019 Jan 9. doi: 10.3892/ijo.2019.4682.
    PubMed     Abstract available
    
    
    
58. ABDELBASET-ISMAIL A, Pedziwiatr D, Schneider G, Niklinski J, et al
    [Corrigendum] Pituitary sex hormones enhance the prometastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase1.
    Int J Oncol. 2019 Jan 3. doi: 10.3892/ijo.2019.4670.
    PubMed     Abstract available
    
    
    
59. WANG S, Gao P, Li N, Chen P, et al
    Autocrine secretions enhance radioresistance in an exosomeindependent manner in NSCLC cells.
    Int J Oncol. 2019;54:229-238.
    PubMed     Abstract available
    
    
    
60. OTHMAN N, Nagoor NH
    Overexpression of miR3615p plays an oncogenic role in human lung adenocarcinoma through the regulation of SMAD2.
    Int J Oncol. 2019;54:306-314.
    PubMed     Abstract available
    
    
    December 2018
61. WEBER R, Meister M, Muley T, Thomas M, et al
    Pathways regulating the expression of the immunomodulatory protein glycodelin in nonsmall cell lung cancer.
    Int J Oncol. 2018 Dec 5. doi: 10.3892/ijo.2018.4654.
    PubMed     Abstract available
    
    
    
62. ZHANG C, Hao Y, Wu L, Dong X, et al
    Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesothelioma.
    Int J Oncol. 2018;53:2531-2541.
    PubMed     Abstract available
    
    
    
63. LIU S, Tang H, Zhu J, Ding H, et al
    High expression of Copine 1 promotes cell growth and metastasis in human lung adenocarcinoma.
    Int J Oncol. 2018;53:2369-2378.
    PubMed     Abstract available
    
    
    November 2018
64. AHMMED B, Khan MN, Nisar MA, Kampo S, et al
    Tunicamycin enhances the suppressive effects of cisplatin on lung cancer growth through PTX3 glycosylation via AKT/NF-kappaB signaling pathway.
    Int J Oncol. 2018 Nov 28. doi: 10.3892/ijo.2018.4650.
    PubMed     Abstract available
    
    
    
65. XU YH, Tu JR, Zhao TT, Xie SG, et al
    Overexpression of lncRNA EGFRAS1 is associated with a poor prognosis and promotes chemotherapy resistance in nonsmall cell lung cancer.
    Int J Oncol. 2018 Nov 9. doi: 10.3892/ijo.2018.4629.
    PubMed     Abstract available
    
    
    
66. CHEN L, Zhou Y, Tang X, Yang C, et al
    EGFR mutation decreases FDG uptake in nonsmall cell lung cancer via the NOX4/ROS/GLUT1 axis.
    Int J Oncol. 2018 Nov 6. doi: 10.3892/ijo.2018.4626.
    PubMed     Abstract available
    
    
    
67. ZHAO H, Chen G, Ye L, Yu H, et al
    DOK7V1 influences the malignant phenotype of lung cancer cells through PI3K/AKT/mTOR and FAK/paxillin signaling pathways.
    Int J Oncol. 2018 Nov 5. doi: 10.3892/ijo.2018.4624.
    PubMed     Abstract available
    
    
    
68. KATO T, Jin CS, Lee D, Ujiie H, et al
    Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma.
    Int J Oncol. 2018;53:2034-2046.
    PubMed     Abstract available
    
    
    October 2018
69. HUANG FX, Chen HJ, Zheng FX, Gao ZY, et al
    LncRNA BLACAT1 is involved in chemoresistance of nonsmall cell lung cancer cells by regulating autophagy.
    Int J Oncol. 2018 Oct 31. doi: 10.3892/ijo.2018.4614.
    PubMed     Abstract available
    
    
    
70. JIANG F, Yu Q, Chu Y, Zhu X, et al
    MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1.
    Int J Oncol. 2018 Oct 29. doi: 10.3892/ijo.2018.4610.
    PubMed     Abstract available
    
    
    
71. ZHANG X, Zhang X, Liu X, Qi P, et al
    MicroRNA-296, a suppressor non-coding RNA, downregulates SGLT2 expression in lung cancer.
    Int J Oncol. 2018 Oct 19. doi: 10.3892/ijo.2018.4599.
    PubMed     Abstract available
    
    
    
72. SUDO H, Tsuji AB, Sugyo A, Okada M, et al
    Direct comparison of 2amino[311C]isobutyric acid and 2amino[11C]methylisobutyric acid uptake in eight lung cancer xenograft models.
    Int J Oncol. 2018 Oct 16. doi: 10.3892/ijo.2018.4596.
    PubMed     Abstract available
    
    
    
73. ZHANG W, Liu K, Pei Y, Ma J, et al
    Mst1 regulates non-small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1/Factin pathways.
    Int J Oncol. 2018 Oct 8. doi: 10.3892/ijo.2018.4586.
    PubMed     Abstract available
    
    
    
74. GAN BL, He RQ, Zhang Y, Wei DM, et al
    Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Int J Oncol. 2018;53:1557-1579.
    PubMed     Abstract available
    
    
    August 2018
75. YOU C, Zhang S, Sun Y, Zhang S, et al
    beta-catenin decreases acquired TRAIL resistance in non-small-cell lung cancer cells by regulating the redistribution of death receptors.
    Int J Oncol. 2018 Aug 21. doi: 10.3892/ijo.2018.4529.
    PubMed     Abstract available
    
    
    
76. LI W, Shi Y, Wang R, Pan L, et al
    Resveratrol promotes the sensitivity of small-cell lung cancer H446 cells to cisplatin by regulating intrinsic apoptosis.
    Int J Oncol. 2018 Aug 21. doi: 10.3892/ijo.2018.4533.
    PubMed     Abstract available
    
    
    
77. CHIU YH, Hsu SH, Hsu HW, Huang KC, et al
    Human nonsmall cell lung cancer cells can be sensitized to camptothecin by modulating autophagy.
    Int J Oncol. 2018 Aug 14. doi: 10.3892/ijo.2018.4523.
    PubMed     Abstract available
    
    
    
78. ABRAHAM V, Cao G, Parambath A, Lawal F, et al
    Involvement of TIMP-1 in PECAM-1-mediated tumor dissemination.
    Int J Oncol. 2018;53:488-502.
    PubMed     Abstract available
    
    
    July 2018
79. TANG Q, Li M, Chen L, Bi F, et al
    miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Int J Oncol. 2018 Jul 20. doi: 10.3892/ijo.2018.4493.
    PubMed     Abstract available
    
    
    
80. ZHOU J, Sun J, Chen H, Peng Q, et al
    Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles.
    Int J Oncol. 2018 Jul 6. doi: 10.3892/ijo.2018.4474.
    PubMed     Abstract available
    
    
    
81. SHEN W, Pang H, Xin B, Duan L, et al
    Biological effects of BMP7 on small-cell lung cancer cells and its bone metastasis.
    Int J Oncol. 2018 Jul 4. doi: 10.3892/ijo.2018.4469.
    PubMed     Abstract available
    
    
    
82. FAN X, Liang Y, Liu Y, Bai Y, et al
    The upregulation of TMPRSS4, partly ascribed to the downregulation of miR125a5p, promotes the growth of human lung adenocarcinoma via the NFkappaB signaling pathway.
    Int J Oncol. 2018;53:148-158.
    PubMed     Abstract available
    
    
    
83. CHANG CC, Liu TY, Lee YT, Chen YC, et al
    Genome-wide analysis of lncRNAs in 3'-untranslated regions: CR933609 acts as a decoy to protect the INO80D gene.
    Int J Oncol. 2018;53:417-433.
    PubMed     Abstract available
    
    
    
84. SUMI T, Hirai S, Yamaguchi M, Tanaka Y, et al
    Survivin knockdown induces senescence in TTF1-expressing, KRAS-mutant lung adenocarcinomas.
    Int J Oncol. 2018;53:33-46.
    PubMed     Abstract available
    
    
    June 2018
85. LUO X, Ye S, Jiang Q, Gong Y, et al
    Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/beta-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
    Int J Oncol. 2018 Jun 15. doi: 10.3892/ijo.2018.4442.
    PubMed     Abstract available
    
    
    
86. ZHAO YY, Wu Q, Wu ZB, Zhang JJ, et al
    Microwave hyperthermia promotes caspase3-dependent apoptosis and induces G2/M checkpoint arrest via the ATM pathway in nonsmall cell lung cancer cells.
    Int J Oncol. 2018 Jun 13. doi: 10.3892/ijo.2018.4439.
    PubMed     Abstract available
    
    
    May 2018
87. FUJIWARA-KURODA A, Kato T, Abiko T, Tsuchikawa T, et al
    Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status.
    Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4425.
    PubMed     Abstract available
    
    
    
88. KANG MA, Kim W, Jo HR, Shin YJ, et al
    Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS032, on cervical cancer.
    Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4424.
    PubMed     Abstract available
    
    
    
89. LIU DH, An M, Bao BL, Ren F, et al
    Nicotine inhibits CD24 expression in Lewis lung carcinoma cells by upregulation of RAS expression.
    Int J Oncol. 2018 May 22. doi: 10.3892/ijo.2018.4415.
    PubMed     Abstract available
    
    
    
90. ZHANG W, Cai X, Yu J, Lu X, et al
    Exosome-mediated transfer of lncRNA RP11838N2.4 promotes erlotinib resistance in non-small cell lung cancer.
    Int J Oncol. 2018 May 17. doi: 10.3892/ijo.2018.4412.
    PubMed     Abstract available
    
    
    
91. SHEN M, Chen Y, Xu L, Zhu R, et al
    Increased infiltration of macrophages to radioresistant lung cancer cells contributes to the development of the additional resistance of tumor cells to the cytotoxic effects of NK cells.
    Int J Oncol. 2018 May 4. doi: 10.3892/ijo.2018.4394.
    PubMed     Abstract available
    
    
    
92. LIU K, Chen H, You Q, Ye Q, et al
    miR145 inhibits human nonsmall-cell lung cancer growth by dual-targeting RIOK2 and NOB1.
    Int J Oncol. 2018 May 3. doi: 10.3892/ijo.2018.4393.
    PubMed     Abstract available
    
    
    April 2018
93. DIAZ-RODRIGUEZ E, Sanz E, Pandiella A
    Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer.
    Int J Oncol. 2018 Apr 16. doi: 10.3892/ijo.2018.4373.
    PubMed     Abstract available
    
    
    
94. ZHANG Y, Li XJ, He RQ, Wang X, et al
    Upregulation of HOXA1 promotes tumorigenesis and development of nonsmall cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis.
    Int J Oncol. 2018 Apr 16. doi: 10.3892/ijo.2018.4372.
    PubMed     Abstract available
    
    
    
95. LI YJ, Sun YX, Hao RM, Wu P, et al
    miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling.
    Int J Oncol. 2018;52:1328-1338.
    PubMed     Abstract available
    
    
    March 2018
96. ZHANG G, Xue P, Cui S, Yu T, et al
    Different splicing isoforms of ERCC1 affect the expression of its overlapping genes CD3EAP and PPP1R13L, and indicate a potential application in non-small cell lung cancer treatment.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4347.
    PubMed     Abstract available
    
    
    
97. ASAKA S, Yoshizawa A, Saito K, Kobayashi Y, et al
    Rapid point-of-care testing for epidermal growth factor receptor gene mutations in patients with lung cancer using cell-free DNA from cytology specimen supernatants.
    Int J Oncol. 2018 Mar 27. doi: 10.3892/ijo.2018.4334.
    PubMed     Abstract available
    
    
    
98. ZHANG L, Lu J, Zhou H, Du Z, et al
    Silencing of aquaporin 5 inhibits the growth of A549 lung cancer cells in vitro and in vivo.
    Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4326.
    PubMed     Abstract available
    
    
    
99. MARUOKA T, Kitanaka A, Kubota Y, Yamaoka G, et al
    Lemongrass essential oil and citral inhibit Src/Stat3 activity and suppress the proliferation/survival of small-cell lung cancer cells, alone or in combination with chemotherapeutic agents.
    Int J Oncol. 2018 Mar 13. doi: 10.3892/ijo.2018.4314.
    PubMed     Abstract available
    
    
    
100. YI L, Sun D, Han Q, Liu Z, et al
     Interferon regulatory factor 3 mediates Poly(I:C)-induced innate immune response and apoptosis in nonsmall cell lung cancer.
     Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4300.
     PubMed     Abstract available
     
     
     
101. KAMINSKA K, Czarnecka AM, Khan MI, Fendler W, et al
     Effects of cell-cell crosstalk on gene expression patterns in a cell model of renal cell carcinoma lung metastasis.
     Int J Oncol. 2018;52:768-786.
     PubMed     Abstract available
     
     
     
102. SUETSUGU T, Koshizuka K, Seki N, Mizuno K, et al
     Downregulation of matrix metalloproteinase 14 by the antitumor miRNA, miR-150-5p, inhibits the aggressiveness of lung squamous cell carcinoma cells.
     Int J Oncol. 2018;52:913-924.
     PubMed     Abstract available
     
     
     February 2018
103. MAJ E, Filip-Psurska B, Milczarek M, Psurski M, et al
     Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
     Int J Oncol. 2018;52:337-366.
     PubMed     Abstract available
     
     
     
104. FRILLE A, Leithner K, Olschewski A, Olschewski H, et al
     No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
     Int J Oncol. 2018;52:518-526.
     PubMed     Abstract available
     
     
     
105. KIM J, Hong SW, Kim S, Kim D, et al
     Cyclooxygenase-2 expression is induced by celecoxib treatment in lung cancer cells and is transferred to neighbor cells via exosomes.
     Int J Oncol. 2018;52:613-620.
     PubMed     Abstract available
     
     
     January 2018
106. ANISIEWICZ A, Pawlik A, Filip-Psurska B, Turlej E, et al
     Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer.
     Int J Oncol. 2018;52:103-126.
     PubMed     Abstract available
     
     
     November 2017
107. RONG B, Yang S
     Molecular mechanism and targeted therapy of Hsp90 involved in lung cancer: New discoveries and developments (Review).
     Int J Oncol. 2017 Nov 29. doi: 10.3892/ijo.2017.4214.
     PubMed     Abstract available
     
     
     
108. SHI J, Guo J, Li X
     Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.
     Int J Oncol. 2017 Nov 10. doi: 10.3892/ijo.2017.4201.
     PubMed     Abstract available
     
     
     October 2017
109. GENG F, Jiang Z, Song X, Zhou H, et al
     Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of nonsmall cell lung cancer via regulating GSK-3beta/beta-catenin signaling.
     Int J Oncol. 2017 Oct 12. doi: 10.3892/ijo.2017.4154.
     PubMed     Abstract available
     
     
     September 2017
110. JUNG SY, Kho S, Song KH, Ahn J, et al
     Novel focal adhesion kinase 1 inhibitor sensitizes lung cancer cells to radiation in a p53-independent manner.
     Int J Oncol. 2017 Sep 29. doi: 10.3892/ijo.2017.4141.
     PubMed     Abstract available
     
     
     
111. YOSHIDA R, Sasaki T, Minami Y, Hibino Y, et al
     Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer.
     Int J Oncol. 2017 Sep 28. doi: 10.3892/ijo.2017.4140.
     PubMed     Abstract available
     
     
     June 2017
112. GU Z, Fang X, Li C, Chen C, et al
     Increased PTPRA expression leads to poor prognosis through c-Src activation and G1 phase progression in squamous cell lung cancer.
     Int J Oncol. 2017 Jun 23. doi: 10.3892/ijo.2017.4055.
     PubMed     Abstract available
     
     
     
113. MAEDA M, Chen Y, Lee S, Kumagai-Takei N, et al
     Induction of IL-17 production from human peripheral blood CD4+ cells by asbestos exposure.
     Int J Oncol. 2017;50:2024-2032.
     PubMed     Abstract available
     
     
     
114. LI Y, Miao L, Yu M, Shi M, et al
     alpha1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression.
     Int J Oncol. 2017;50:1955-1964.
     PubMed     Abstract available
     
     
     May 2017
115. PANG L, Han S, Jiao Y, Jiang S, et al
     Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
     Int J Oncol. 2017 May 19. doi: 10.3892/ijo.2017.4014.
     PubMed     Abstract available
     
     
     
116. LI X, Han J, Zhu H, Peng L, et al
     miR181b5p mediates TGFbeta1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.
     Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4007.
     PubMed     Abstract available
     
     
     
117. LU C, Shan Z, Hong J, Yang L, et al
     MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
     Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.3999.
     PubMed     Abstract available
     
     
     
118. WANG C, Chen K, Liao S, Gu W, et al
     The flightless I protein interacts with RNA-binding proteins and is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells.
     Int J Oncol. 2017 May 11. doi: 10.3892/ijo.2017.3995.
     PubMed     Abstract available
     
     
     
119. UJIIE H, Kato T, Lee D, Hu HP, et al
     Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.
     Int J Oncol. 2017 May 5. doi: 10.3892/ijo.2017.3984.
     PubMed     Abstract available
     
     
     April 2017
120. SHI B, Wang LF, Meng WS, Chen L, et al
     Carnosic acid and fisetin combination therapy enhances inhibition of lung cancer through apoptosis induction.
     Int J Oncol. 2017 Apr 20. doi: 10.3892/ijo.2017.3970.
     PubMed     Abstract available
     
     
     
121. LIU C, Lv D, Li M, Zhang X, et al
     Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer.
     Int J Oncol. 2017 Apr 20. doi: 10.3892/ijo.2017.3967.
     PubMed     Abstract available
     
     
     
122. LU S, Dong Z
     Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells.
     Int J Oncol. 2017 Apr 19. doi: 10.3892/ijo.2017.3964.
     PubMed     Abstract available
     
     
     March 2017
123. YAMAMOTO G, Kikuchi M, Kobayashi S, Arai Y, et al
     Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.
     Int J Oncol. 2017 Mar 27. doi: 10.3892/ijo.2017.3935.
     PubMed     Abstract available
     
     
     
124. TAN Q, Zuo J, Qiu S, Yu Y, et al
     Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.
     Int J Oncol. 2017 Mar 22. doi: 10.3892/ijo.2017.3925.
     PubMed     Abstract available
     
     
     
125. MAWAS AS, Amatya VJ, Suzuki R, Kushitani K, et al
     PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells.
     Int J Oncol. 2017;50:1029-1034.
     PubMed     Abstract available
     
     
     
126. CREGAN S, Breslin M, Roche G, Wennstedt S, et al
     Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.
     Int J Oncol. 2017;50:1044-1052.
     PubMed     Abstract available
     
     
     February 2017
127. PANAGOPOULOS V, Leach DA, Zinonos I, Ponomarev V, et al
     Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
     Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3883.
     PubMed     Abstract available
     
     
     
128. KANG H, Zhang J, Wang B, Liu M, et al
     Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway.
     Int J Oncol. 2017;50:545-554.
     PubMed     Abstract available
     
     
     
129. CHEN L, Wang L, Yan J, Ma C, et al
     131I-labeled monoclonal antibody targeting neuropilin receptor type-2 for tumor SPECT imaging.
     Int J Oncol. 2017;50:649-659.
     PubMed     Abstract available
     
     
     January 2017
130. LEE S, Matsuzaki H, Maeda M, Yamamoto S, et al
     Accelerated cell cycle progression of human regulatory T cell-like cell line caused by continuous exposure to asbestos fibers.
     Int J Oncol. 2017;50:66-74.
     PubMed     Abstract available
     
     
     December 2016
131. IM M, Kim A, Ma JY
     Ethanol extract of baked Gardeniae Fructus exhibits in vitro and in vivo anti-metastatic and anti-angiogenic activities in malignant cancer cells: Role of suppression of the NF-kappaB and HIF-1alpha pathways.
     Int J Oncol. 2016;49:2377-2386.
     PubMed     Abstract available
     
     
     
132. KATO T, Lee D, Wu L, Patel P, et al
     SORORIN and PLK1 as potential therapeutic targets in malignant pleural mesothelioma.
     Int J Oncol. 2016;49:2411-2420.
     PubMed     Abstract available
     
     
     
133. HWANG SJ, Park HG, Park Y, Lee HJ, et al
     An alpha-quaternary chiral latam derivative, YH-304 as a novel broad-spectrum anticancer agent.
     Int J Oncol. 2016;49:2480-2486.
     PubMed     Abstract available
     
     
     November 2016
134. KUMAMOTO T, Seki N, Mataki H, Mizuno K, et al
     Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
     Int J Oncol. 2016;49:1870-1880.
     PubMed     Abstract available
     
     
     October 2016
135. ZHOU H, Li J, Zhang Z, Ye R, et al
     RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
     Int J Oncol. 2016 Oct 5. doi: 10.3892/ijo.2016.3718.
     PubMed     Abstract available
     
     
     
136. TANAKA T, Imamura T, Yoneda M, Irie A, et al
     Enhancement of active MMP release and invasive activity of lymph node metastatic tongue cancer cells by elevated signaling via the TNF-alpha-TNFR1-NF-kappaB pathway and a possible involvement of angiopoietin-like 4 in lung metastasis.
     Int J Oncol. 2016;49:1377-84.
     PubMed     Abstract available
     
     
     
137. NOGIMORI K, Hori T, Kawaguchi K, Fukui T, et al
     Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosis.
     Int J Oncol. 2016;49:1369-76.
     PubMed     Abstract available
     
     
     
138. QIN S, Yang C, Zhang B, Li X, et al
     XIAP inhibits mature Smac-induced apoptosis by degrading it through ubiquitination in NSCLC.
     Int J Oncol. 2016;49:1289-96.
     PubMed     Abstract available
     
     
     September 2016
139. KIM JS, Kang SJ, Jeong HY, Kim MW, et al
     Anti-EGFR immunonanoparticles containing IL12 and salmosin genes for targeted cancer gene therapy.
     Int J Oncol. 2016;49:1130-8.
     PubMed     Abstract available
     
     
     
140. ZHONG N, Shi S, Wang H, Wu G, et al
     Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells.
     Int J Oncol. 2016;49:1028-38.
     PubMed     Abstract available
     
     
     August 2016
141. ZENG Y, Zhu J, Shen D, Qin H, et al
     Repression of Smad4 by miR205 moderates TGF-beta-induced epithelial-mesenchymal transition in A549 cell lines.
     Int J Oncol. 2016;49:700-8.
     PubMed     Abstract available
     
     
     July 2016
142. CHEN M, Guo Y, Zhao R, Wang X, et al
     Ophiopogonin B induces apoptosis, mitotic catastrophe and autophagy in A549 cells.
     Int J Oncol. 2016;49:316-24.
     PubMed     Abstract available
     
     
     June 2016
143. WU D, Mou YP, Chen K, Cai JQ, et al
     Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
     Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3551.
     PubMed     Abstract available
     
     
     May 2016
144. KWON YS, Lee KS, Chun SY, Jang TJ, et al
     Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
     Int J Oncol. 2016 May 13. doi: 10.3892/ijo.2016.3520.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: